Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Zoellner, Anna-Katharina [VerfasserIn]   i
 Herfarth, Klaus [VerfasserIn]   i
 Herold, Michael [VerfasserIn]   i
 Klapper, Wolfram [VerfasserIn]   i
 Skoetz, Nicole [VerfasserIn]   i
 Hiddemann, Wolfgang [VerfasserIn]   i
Titel:Follicular lymphoma
Titelzusatz:diagnosis, treatment, and follow-up
Verf.angabe:Anna Zoellner, Klaus Herfarth, Michael Herold, Wolfram Klapper, Nicole Skoetz, Wolfgang Hiddemann
E-Jahr:2021
Jahr:May 7, 2021
Umfang:6 S.
Teil:volume:118
 year:2021
 number:18
 pages:320-325
 extent:6
Fussnoten:Gesehen am 12.08.2021
Titel Quelle:Enthalten in: Deutsches Ärzteblatt international
Ort Quelle:Köln : Dt. Ärzte-Verl., 2006
Jahr Quelle:2021
Band/Heft Quelle:118(2021), 18, Seite 320-325
ISSN Quelle:1866-0452
Abstract:Background: Follicular lymphoma (FL) occurs predominantly at advanced age, with an annual incidence of 3-5 cases per 100 000 inhabitants in Western countries. The clinical course is heterogeneous. - Methods: For this new guideline, systematic literature searches were conducted in medical databases (MEDLINE, PubMed Central) (up to November 2017) and in the Guidelines International Network (G-I-N), and recent publications were added. - Results: The results of 21 systematic reviews with meta-analyses, 75 randomized controlled trials, and 58 prospective and retrospective studies were evaluated. Lymph-node biopsy is necessary for initial diagnosis of FL. CT scanning of the neck, thorax, and abdomen should be performed to assess how far the disease has spread, together with bone marrow biopsy and, if required, PET/CT. In early FL (stages I and II; 10-15 %), potentially curative radiotherapy combined with an antiCD 20 antibody is recommended. In advanced disease (stages III and IV), watchful waiting is indicated for patients who have no clinical symptoms and a low tumor burden. Patients with clinical symptoms and/or high tumor burden should receive chemotherapy in combination with an anti-CD 20 antibody, followed by 2 years’ maintenance treatment with an anti-CD 20 antibody. - Conclusion: Given the good long-term prognosis of FL, the treatment must be chosen with care and thorough follow-up is necessary to ensure detection of late sequelae such as second malignancies or organ damage.
DOI:doi:10.3238/arztebl.m2021.0022
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.3238/arztebl.m2021.0022
 Volltext: https://www.aerzteblatt.de/10.3238/arztebl.m2021.0022
 DOI: https://doi.org/10.3238/arztebl.m2021.0022
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1766547877
Verknüpfungen:→ Zeitung

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68770200   QR-Code
zum Seitenanfang